Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Luxturna
Luxturna
Spark Therapeutics faces a grilling as FDA ponders a pioneering OK for gene therapy
Endpoints
Tue, 10/10/17 - 09:38 am
Spark Therapeutics
FDA
gene therapy
Luxturna
retinal dystrophies
FDA embraces the first US application for a gene therapy, offering an accelerated test case
Endpoints
Mon, 07/17/17 - 09:59 am
FDA
gene therapy
Spark Therapeutics
Luxturna
RPE65-mediated inherited retinal disease
Pages
« first
‹ previous
1
2